Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate

BACKGROUND: Treatment options for melanoma in situ (MIS) include imiquimod, radiation therapy, cryotherapy, excisional and Mohs surgery. Ingenol mebutate is a new topical treatment option recognized for actinic keratosis. Although in vitro effectiveness has been demonstrated on melanoma cell lines,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansuy, Marion, Nikkels-Tassoudji, Nazli, Arrese, Jorge E., Rorive, Andree, Nikkels, Arjen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065276/
https://www.ncbi.nlm.nih.gov/pubmed/24691652
http://dx.doi.org/10.1007/s13555-014-0051-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065276/
https://www.ncbi.nlm.nih.gov/pubmed/24691652
http://dx.doi.org/10.1007/s13555-014-0051-4

Ejemplares similares